Biotechnology
The Biotechnology industry has a total of 589 stocks, with a combined market cap of $1.09 trillion and total revenue of $110.29 billion.
Market Cap
1.09T
Revenue
110.29B
Profits
-41.75B
PE Ratio
n/a
Profit Margin
-37.85%
Dividend Yield
0.04%
589 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.81B | -0.08% | 1,443,884 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 64.06B | -9.82% | 2,817,972 | 14.92B |
| 3 | ARGX | argenx SE | 48.90B | -2.88% | 306,674 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.22B | -0.25% | 873,353 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 32.58B | -0.06% | 215,036 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.69B | -0.89% | 2,327,416 | - |
| 7 | RPRX | Royalty Pharma plc | 29.98B | -1.48% | 2,784,383 | 2.44B |
| 8 | INSM | Insmed Incorporated | 23.23B | -1.82% | 3,833,943 | 819.56M |
| 9 | BNTX | BioNTech SE | 22.47B | -0.78% | 982,841 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.43B | -2.53% | 14,716,597 | 13.31M |
| 11 | MRNA | Moderna, Inc. | 19.09B | -1.90% | 4,330,372 | 2.23B |
| 12 | INCY | Incyte Corporation | 19.02B | -0.13% | 1,020,838 | 5.36B |
| 13 | GMAB | Genmab A/S | 16.12B | -0.68% | 2,858,079 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 14.76B | -1.19% | 582,024 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.40B | 0.34% | 685,869 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 12.79B | -1.22% | 3,038,437 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 12.53B | -0.58% | 2,596,012 | 2.38B |
| 18 | SMMT | Summit Therapeutics Inc. | 12.43B | -5.04% | 4,418,076 | - |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.04B | -0.28% | 325,809 | 1.13B |
| 20 | IONS | Ionis Pharmaceuticals, Inc. | 11.98B | -2.30% | 2,210,752 | 1.06B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.70B | -0.14% | 464,486 | 708.24M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.42B | -3.55% | 1,511,578 | 622.01M |
| 23 | CYTK | Cytokinetics, Incorporated | 10.21B | -0.88% | 1,797,610 | 105.82M |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 9.60B | -4.13% | 3,484,941 | 3.24B |
| 25 | ABVX | ABIVAX Société Anonyme | 9.11B | -0.86% | 798,035 | 5.37M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 8.94B | -6.44% | 329,996 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.60B | -4.75% | 298,839 | 417.30M |
| 28 | IBRX | ImmunityBio, Inc. | 8.38B | 0.38% | 13,028,011 | 140.98M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.00B | 0.48% | 1,780,673 | 1.51B |
| 30 | NUVL | Nuvalent, Inc. | 7.89B | -2.34% | 440,685 | - |
| 31 | PCVX | Vaxcyte, Inc. | 6.99B | -7.60% | 1,715,045 | - |
| 32 | TECH | Bio-Techne Corporation | 6.96B | 2.61% | 4,101,875 | 1.21B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.55B | -3.09% | 677,931 | 51.48M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 6.48B | -1.41% | 346,098 | 74.06M |
| 35 | CELC | Celcuity Inc. | 6.39B | -3.99% | 721,355 | - |
| 36 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.14% | 909,224 | 15.00M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 6.10B | -6.19% | 1,064,447 | - |
| 38 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.95B | -4.09% | 647,630 | 217.17M |
| 39 | CORT | Corcept Therapeutics Incorporated | 5.92B | -2.22% | 816,392 | 769.10M |
| 40 | APGE | Apogee Therapeutics, Inc. | 5.90B | -2.95% | 748,120 | - |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.82B | -6.55% | 1,011,544 | 569.61M |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.82B | -1.85% | 833,986 | 827.11M |
| 43 | SRRK | Scholar Rock Holding Corporation | 5.68B | -3.99% | 909,777 | - |
| 44 | BLTE | Belite Bio, Inc | 5.62B | -0.12% | 104,210 | - |
| 45 | TGTX | TG Therapeutics, Inc. | 5.60B | -0.05% | 1,602,642 | 700.35M |
| 46 | CGON | CG Oncology, Inc. | 5.55B | -5.98% | 1,378,280 | 5.07M |
| 47 | IMVT | Immunovant, Inc. | 5.40B | -3.49% | 1,275,136 | - |
| 48 | COGT | Cogent Biosciences, Inc. | 5.36B | -4.04% | 1,631,114 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.19B | -1.25% | 667,614 | 7.50M |
| 50 | LEGN | Legend Biotech Corporation | 5.01B | -2.00% | 1,773,985 | 1.14B |
| 51 | CRSP | CRISPR Therapeutics AG | 4.68B | 0.31% | 1,778,281 | 4.10M |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 4.56B | -3.09% | 596,789 | 1.34M |
| 53 | CAI | Caris Life Sciences, Inc. | 4.27B | 3.78% | 5,405,306 | 907.29M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.17B | -2.50% | 140,393 | 274.48M |
| 55 | MANE | Veradermics, Incorporated | 4.13B | 0.66% | 434,708 | - |
| 56 | TVTX | Travere Therapeutics, Inc. | 3.99B | 0.70% | 1,496,199 | 536.20M |
| 57 | NAMS | NewAmsterdam Pharma Company N.V. | 3.93B | -3.67% | 1,959,430 | 22.57M |
| 58 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | 0.16% | 4,170,363 | 596.96M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.66B | -5.63% | 822,685 | 18.07M |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 3.54B | -3.32% | 1,601,124 | 1.10B |
| 61 | ORKA | Oruka Therapeutics, Inc. | 3.52B | -5.80% | 1,905,861 | - |
| 62 | TLX | Telix Pharmaceuticals Limited | 3.46B | -2.65% | 83,695 | 803.79M |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.41B | -4.14% | 940,141 | - |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.33B | -5.22% | 3,337,961 | - |
| 65 | ERAS | Erasca, Inc. | 3.19B | 0.39% | 2,315,998 | - |
| 66 | TNGX | Tango Therapeutics, Inc. | 2.98B | 0.34% | 3,230,963 | 56.99M |
| 67 | RCUS | Arcus Biosciences, Inc. | 2.94B | -1.60% | 970,315 | 236.00M |
| 68 | DNLI | Denali Therapeutics Inc. | 2.92B | -1.18% | 1,692,101 | - |
| 69 | SLNO | Soleno Therapeutics, Inc. | 2.76B | - | - | 285.01M |
| 70 | DYN | Dyne Therapeutics, Inc. | 2.73B | -4.34% | 1,584,899 | - |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.70B | 0.54% | 546,879 | 535.08M |
| 72 | ALMS | Alumis Inc. | 2.70B | -7.52% | 1,280,682 | 8.40M |
| 73 | BEAM | Beam Therapeutics Inc. | 2.67B | -4.01% | 2,001,874 | 164.01M |
| 74 | GPCR | Structure Therapeutics Inc. | 2.57B | -6.67% | 740,529 | - |
| 75 | IRON | Disc Medicine, Inc. | 2.55B | 0.04% | 582,175 | - |
| 76 | KLRA | Kailera Therapeutics, Inc. | 2.53B | -7.08% | 601,971 | - |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 2.51B | -6.05% | 1,100,300 | 415.62M |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 2.49B | 0.39% | 875,971 | 225.27M |
| 79 | NBTX | Nanobiotix S.A. | 2.47B | -3.94% | 38,229 | 38.27M |
| 80 | VERA | Vera Therapeutics, Inc. | 2.47B | -7.96% | 1,597,215 | - |
| 81 | ELVN | Enliven Therapeutics, Inc. | 2.42B | -4.04% | 452,336 | - |
| 82 | RARE | Ultragenyx Pharmaceutical Inc. | 2.38B | -3.24% | 1,168,919 | 670.00M |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.37B | -3.57% | 825,943 | 865.00K |
| 84 | RLAY | Relay Therapeutics, Inc. | 2.32B | -0.82% | 2,296,267 | 10.68M |
| 85 | NKTR | Nektar Therapeutics | 2.31B | -3.10% | 1,204,823 | 55.63M |
| 86 | IMNM | Immunome, Inc. | 2.25B | -4.69% | 1,327,413 | 4.02M |
| 87 | DFTX | Definium Therapeutics, Inc. | 2.23B | -2.43% | 1,171,647 | - |
| 88 | KOD | Kodiak Sciences Inc. | 2.19B | -5.40% | 599,002 | - |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.18B | -3.62% | 836,987 | - |
| 90 | TYRA | Tyra Biosciences, Inc. | 2.12B | -3.73% | 660,937 | - |
| 91 | ZLAB | Zai Lab Limited | 2.12B | -8.40% | 1,649,189 | 453.28M |
| 92 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | 2.09% | 1,205,289 | 298.30M |
| 93 | ADMA | ADMA Biologics, Inc. | 1.94B | 1.33% | 3,351,522 | 509.86M |
| 94 | TRVI | Trevi Therapeutics, Inc. | 1.91B | -5.42% | 1,410,111 | - |
| 95 | MESO | Mesoblast Limited | 1.89B | -2.33% | 161,924 | 65.38M |
| 96 | PHVS | Pharvaris N.V. | 1.88B | -5.23% | 305,721 | - |
| 97 | OCUL | Ocular Therapeutix, Inc. | 1.83B | -8.52% | 2,983,887 | 52.04M |
| 98 | STOK | Stoke Therapeutics, Inc. | 1.81B | -3.32% | 736,426 | 32.08M |
| 99 | SRPT | Sarepta Therapeutics, Inc. | 1.80B | -3.08% | 3,388,566 | 2.18B |
| 100 | ZYME | Zymeworks Inc. | 1.78B | 2.09% | 673,109 | 81.26M |
| 101 | VCEL | Vericel Corporation | 1.78B | 5.57% | 431,907 | 292.09M |
| 102 | VRDN | Viridian Therapeutics, Inc. | 1.78B | -4.28% | 2,360,299 | 70.92M |
| 103 | NTLA | Intellia Therapeutics, Inc. | 1.77B | -7.17% | 9,625,004 | 66.09M |
| 104 | SION | Sionna Therapeutics, Inc. | 1.77B | -2.44% | 294,099 | - |
| 105 | AAPG | Ascentage Pharma Group International | 1.77B | -4.82% | 9,241 | 82.08M |
| 106 | LKFT | Lakefront Biotherapeutics NV | 1.76B | -1.33% | 212,557 | 1.20B |
| 107 | HRMY | Harmony Biosciences Holdings, Inc. | 1.73B | -0.86% | 396,835 | 899.11M |
| 108 | SNDX | Syndax Pharmaceuticals, Inc. | 1.72B | -4.03% | 1,325,618 | 217.17M |
| 109 | ANAB | AnaptysBio, Inc. | 1.71B | -6.98% | 534,943 | 232.39M |
| 110 | RAPP | Rapport Therapeutics, Inc. | 1.68B | -5.10% | 187,285 | 20.00M |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 1.68B | 0.14% | 757,912 | 66.05M |
| 112 | OCS | Oculis Holding AG | 1.66B | -7.33% | 390,108 | 1.40M |
| 113 | GENB | Generate Biomedicines, Inc. | 1.66B | -18.72% | 1,805,128 | 30.30M |
| 114 | CAPR | Capricor Therapeutics, Inc. | 1.62B | -2.69% | 788,551 | 11.13M |
| 115 | INVA | Innoviva, Inc. | 1.61B | -0.75% | 669,017 | 420.69M |
| 116 | NRIX | Nurix Therapeutics, Inc. | 1.60B | -2.18% | 2,194,363 | 71.78M |
| 117 | QURE | uniQure N.V. | 1.57B | -7.84% | 1,628,828 | 18.09M |
| 118 | TSHA | Taysha Gene Therapies, Inc. | 1.56B | -8.64% | 2,292,880 | 7.47M |
| 119 | INBX | Inhibrx Biosciences, Inc. | 1.55B | -2.61% | 374,626 | 1.30M |
| 120 | RXRX | Recursion Pharmaceuticals, Inc. | 1.53B | -1.37% | 17,637,411 | 66.41M |
| 121 | ATAI | AtaiBeckley Inc. | 1.52B | 3.36% | 7,548,021 | 3.49M |
| 122 | GLUE | Monte Rosa Therapeutics, Inc. | 1.52B | -0.77% | 628,024 | 42.95M |
| 123 | IOVA | Iovance Biotherapeutics, Inc. | 1.51B | -1.74% | 9,023,148 | 285.61M |
| 124 | ARDX | Ardelyx, Inc. | 1.51B | -1.93% | 3,241,709 | 427.68M |
| 125 | PVLA | Palvella Therapeutics, Inc. | 1.51B | -8.04% | 305,393 | - |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.50B | 1.02% | 522,705 | - |
| 127 | GHRS | GH Research PLC | 1.49B | 1.36% | 357,863 | - |
| 128 | VIR | Vir Biotechnology, Inc. | 1.48B | -0.23% | 1,273,476 | 65.50M |
| 129 | MBX | MBX Biosciences, Inc. | 1.47B | -4.53% | 860,478 | - |
| 130 | NVAX | Novavax, Inc. | 1.47B | -1.43% | 4,404,886 | 596.34M |
| 131 | NUVB | Nuvation Bio Inc. | 1.47B | -2.55% | 4,618,188 | 143.05M |
| 132 | PGEN | Precigen, Inc. | 1.45B | -7.92% | 5,171,656 | 31.60M |
| 133 | IMCR | Immunocore Holdings plc | 1.44B | 1.14% | 237,987 | 412.81M |
| 134 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | 0.11% | 1,945,926 | 114.48M |
| 135 | IMTX | Immatics N.V. | 1.42B | -2.30% | 603,336 | 43.00M |
| 136 | URGN | UroGen Pharma Ltd. | 1.39B | -0.78% | 764,687 | 140.49M |
| 137 | SLS | SELLAS Life Sciences Group, Inc. | 1.36B | 2.97% | 8,875,102 | - |
| 138 | MAZE | Maze Therapeutics, Inc. | 1.36B | -4.15% | 543,389 | 20.00M |
| 139 | FTRE | Fortrea Holdings Inc. | 1.29B | -0.59% | 998,134 | 2.71B |
| 140 | BHVN | Biohaven Ltd. | 1.28B | -3.08% | 2,105,849 | - |
| 141 | ABCL | AbCellera Biologics Inc. | 1.27B | 1.71% | 10,871,804 | 79.21M |
| 142 | BCAX | Bicara Therapeutics Inc. | 1.27B | -4.67% | 510,389 | - |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.26B | -2.98% | 298,705 | - |
| 144 | SVRA | Savara Inc. | 1.25B | -2.39% | 1,769,623 | - |
| 145 | WVE | Wave Life Sciences Ltd. | 1.23B | -5.47% | 6,448,089 | 71.80M |
| 146 | MPLT | MapLight Therapeutics, Inc. | 1.20B | -7.87% | 535,022 | - |
| 147 | COAG | Hemab Therapeutics Holdings, Inc. | 1.20B | -3.35% | 151,177 | - |
| 148 | MLTX | MoonLake Immunotherapeutics | 1.20B | -6.32% | 931,188 | - |
| 149 | SEPN | Septerna, Inc. | 1.19B | -2.41% | 316,920 | 72.26M |
| 150 | DBVT | DBV Technologies S.A. | 1.13B | -4.78% | 174,369 | 5.74M |
| 151 | OLMA | Olema Pharmaceuticals, Inc. | 1.13B | -5.08% | 1,636,600 | - |
| 152 | AVLN | Avalyn Pharma Inc. | 1.11B | -10.76% | 429,961 | - |
| 153 | JBIO | Jade Biosciences, Inc. | 1.09B | -5.80% | 374,595 | - |
| 154 | ZBIO | Zenas BioPharma, Inc. | 1.07B | -7.80% | 1,162,624 | 10.00M |
| 155 | IVA | Inventiva S.A. | 1.06B | -7.72% | 238,000 | 7.94M |
| 156 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.05B | -1.57% | 2,154,028 | 204.73M |
| 157 | AKTS | Aktis Oncology, Inc. | 1.03B | -4.50% | 155,829 | 8.28M |
| 158 | CRVS | Corvus Pharmaceuticals, Inc. | 1.03B | -0.81% | 2,558,216 | - |
| 159 | EYPT | EyePoint, Inc. | 980.94M | -5.26% | 731,865 | 7.61M |
| 160 | LXRX | Lexicon Pharmaceuticals, Inc. | 950.38M | -4.04% | 2,209,984 | 69.64M |
| 161 | MNKD | MannKind Corporation | 923.76M | -3.24% | 5,149,034 | 360.78M |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 913.88M | -5.47% | 1,940,962 | - |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 904.71M | -4.04% | 1,225,732 | 204.89M |
| 164 | PHAR | Pharming Group N.V. | 892.68M | -2.32% | 18,809 | 369.49M |
| 165 | DRTS | Alpha Tau Medical Ltd. | 882.74M | -3.19% | 902,398 | - |
| 166 | MGTX | MeiraGTx Holdings plc | 870.53M | - | 553,345 | 79.76M |
| 167 | JANX | Janux Therapeutics, Inc. | 855.61M | 1.01% | 725,947 | 13.73M |
| 168 | OMER | Omeros Corporation | 846.79M | -4.49% | 1,837,403 | 9.89M |
| 169 | SANA | Sana Biotechnology, Inc. | 846.01M | -0.98% | 2,949,089 | - |
| 170 | SPTX | Seaport Therapeutics, Inc. | 845.53M | -5.12% | 421,784 | - |
| 171 | TBPH | Theravance Biopharma, Inc. | 838.25M | 0.25% | 371,934 | 109.78M |
| 172 | AURA | Aura Biosciences, Inc. | 823.94M | -3.49% | 987,425 | - |
| 173 | ABUS | Arbutus Biopharma Corporation | 823.73M | -1.65% | 748,739 | 191.45M |
| 174 | ORIC | ORIC Pharmaceuticals, Inc. | 820.89M | -2.70% | 1,225,516 | - |
| 175 | ODTX | Odyssey Therapeutics, Inc. | 820.36M | -1.31% | 371,797 | 2.98M |
| 176 | XNCR | Xencor, Inc. | 820.01M | -1.43% | 705,710 | 97.36M |
| 177 | KURA | Kura Oncology, Inc. | 816.72M | -0.22% | 1,119,812 | 71.64M |
| 178 | ANNX | Annexon, Inc. | 812.66M | -4.80% | 2,919,399 | - |
| 179 | LBRX | LB Pharmaceuticals Inc | 795.20M | -6.51% | 229,196 | - |
| 180 | AVTX | Avalo Therapeutics, Inc. | 792.75M | -8.91% | 2,540,430 | 59.00K |
| 181 | GERN | Geron Corporation | 789.07M | -4.65% | 10,331,125 | 196.12M |
| 182 | EVMN | Evommune, Inc. | 788.44M | -4.49% | 523,238 | 10.00M |
| 183 | ABSI | Absci Corporation | 770.95M | -3.61% | 3,195,013 | 1.84M |
| 184 | VOR | Vor Biopharma Inc. | 765.64M | -3.42% | 772,766 | - |
| 185 | ANRO | Alto Neuroscience, Inc. | 764.15M | -5.13% | 653,074 | - |
| 186 | CTMX | CytomX Therapeutics, Inc. | 761.96M | -3.05% | 2,640,117 | 35.54M |
| 187 | SGP | SpyGlass Pharma, Inc. | 744.41M | -4.05% | 40,663 | - |
| 188 | DRUG | Bright Minds Biosciences Inc. | 728.19M | -3.19% | 351,024 | - |
| 189 | SPRY | ARS Pharmaceuticals, Inc. | 724.91M | -1.68% | 2,142,789 | 98.99M |
| 190 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 701.89M | 3.06% | 558,873 | - |
| 191 | TENX | Tenax Therapeutics, Inc. | 684.17M | -3.01% | 805,257 | - |
| 192 | ALLO | Allogene Therapeutics, Inc. | 669.60M | -3.00% | 6,368,776 | 22.00K |
| 193 | DSGN | Design Therapeutics, Inc. | 668.29M | -25.54% | 7,574,932 | - |
| 194 | RLMD | Relmada Therapeutics, Inc. | 663.42M | -8.33% | 2,332,563 | - |
| 195 | SLDB | Solid Biosciences Inc. | 640.91M | -5.92% | 1,027,635 | - |
| 196 | EIKN | Eikon Therapeutics, Inc. | 636.13M | -11.32% | 795,687 | - |
| 197 | TRAX | First Tracks Biotherapeutics, Inc. | 620.74M | 5.27% | 365,869 | - |
| 198 | CRMD | CorMedix Inc. | 620.55M | 4.77% | 2,003,566 | 400.05M |
| 199 | ZVRA | Zevra Therapeutics, Inc. | 616.57M | -5.27% | 2,269,442 | 122.29M |
| 200 | CBIO | Crescent Biopharma, Inc. | 616.40M | -7.11% | 416,081 | 11.88M |
| 201 | ACRS | Aclaris Therapeutics, Inc. | 614.52M | -2.65% | 1,827,846 | 8.37M |
| 202 | GYRE | Gyre Therapeutics, Inc. | 587.52M | -1.83% | 75,609 | 117.05M |
| 203 | CADL | Candel Therapeutics, Inc. | 578.83M | -9.92% | 4,171,332 | - |
| 204 | STRO | Sutro Biopharma, Inc. | 571.26M | -11.52% | 408,353 | 99.61M |
| 205 | ARVN | Arvinas, Inc. | 566.50M | -3.30% | 954,692 | 89.40M |
| 206 | VALN | Valneva SE | 544.53M | 0.35% | 10,308 | 180.25M |
| 207 | ALT | Altimmune, Inc. | 544.53M | -1.75% | 3,442,119 | 36.00K |
| 208 | CABA | Cabaletta Bio, Inc. | 536.43M | -0.60% | 2,501,089 | - |
| 209 | MDXG | MiMedx Group, Inc. | 536.20M | 1.12% | 1,007,686 | 389.42M |
| 210 | FBRX | Forte Biosciences, Inc. | 535.89M | -8.57% | 357,791 | - |
| 211 | RIGL | Rigel Pharmaceuticals, Inc. | 529.34M | -1.38% | 448,519 | 299.77M |
| 212 | TECX | Tectonic Therapeutic, Inc. | 522.68M | -0.68% | 377,836 | - |
| 213 | XOMA | XOMA Royalty Corporation | 522.08M | -0.29% | 89,198 | 48.56M |
| 214 | AGMB | AgomAb Therapeutics NV | 520.06M | 0.09% | 64,394 | - |
| 215 | KYTX | Kyverna Therapeutics, Inc. | 516.93M | -10.01% | 1,426,819 | - |
| 216 | PRME | Prime Medicine, Inc. | 507.54M | -4.10% | 3,434,356 | 4.03M |
| 217 | PRTA | Prothena Corporation plc | 502.07M | -1.74% | 650,972 | 57.94M |
| 218 | ACHV | Achieve Life Sciences, Inc. | 489.68M | -9.83% | 2,431,226 | - |
| 219 | PROK | ProKidney Corp. | 486.16M | -3.01% | 966,169 | 889.00K |
| 220 | DNA | Ginkgo Bioworks Holdings, Inc. | 481.44M | -4.41% | 1,039,640 | 151.40M |
| 221 | CTNM | Contineum Therapeutics, Inc. | 480.79M | -6.27% | 55,154 | - |
| 222 | AUTL | Autolus Therapeutics plc | 479.06M | 10.43% | 5,943,341 | 92.62M |
| 223 | IMMX | Immix Biopharma, Inc. | 476.58M | -9.56% | 805,769 | - |
| 224 | CLYM | Climb Bio, Inc. | 471.95M | -8.52% | 628,335 | - |
| 225 | ANL | Adlai Nortye Ltd. | 464.40M | -14.06% | 344,018 | 5.00M |
| 226 | UPB | Upstream Bio, Inc. | 463.11M | -6.38% | 511,282 | 3.32M |
| 227 | OCGN | Ocugen, Inc. | 453.62M | -3.60% | 6,548,743 | 4.47M |
| 228 | STTK | Shattuck Labs, Inc. | 451.22M | -4.63% | 600,832 | 1.00M |
| 229 | ARTV | Artiva Biotherapeutics, Inc. | 447.98M | -5.73% | 517,404 | 251.00K |
| 230 | NGNE | Neurogene Inc. | 442.06M | -6.19% | 176,813 | 925.00K |
| 231 | VTVT | vTv Therapeutics Inc. | 440.41M | -0.57% | 45,073 | 36.84M |
| 232 | FDMT | 4D Molecular Therapeutics, Inc. | 437.29M | -8.58% | 1,019,722 | 88.24M |
| 233 | PRLD | Prelude Therapeutics Incorporated | 436.51M | -3.13% | 440,878 | 16.72M |
| 234 | ASMB | Assembly Biosciences, Inc. | 435.78M | -4.29% | 204,144 | 71.10M |
| 235 | PRTC | PureTech Health plc | 431.03M | -3.79% | 5,433 | 4.66M |
| 236 | EPRX | Eupraxia Pharmaceuticals Inc. | 426.36M | -3.32% | 165,093 | - |
| 237 | OVID | Ovid Therapeutics Inc. | 417.02M | -8.37% | 1,340,110 | 7.12M |
| 238 | REPL | Replimune Group, Inc. | 413.69M | -4.02% | 5,113,623 | - |
| 239 | SGMT | Sagimet Biosciences Inc. | 411.27M | -3.48% | 1,084,850 | - |
| 240 | IPSC | Century Therapeutics, Inc. | 411.21M | -2.56% | 1,349,079 | 109.16M |
| 241 | FULC | Fulcrum Therapeutics, Inc. | 405.80M | -8.97% | 563,333 | 80.00M |
| 242 | ADCT | ADC Therapeutics SA | 403.20M | -2.46% | 1,379,370 | 79.18M |
| 243 | ENTA | Enanta Pharmaceuticals, Inc. | 391.10M | 0.30% | 259,229 | 69.21M |
| 244 | ZURA | Zura Bio Limited | 390.91M | -12.71% | 677,987 | - |
| 245 | LYEL | Lyell Immunopharma, Inc. | 385.22M | -7.87% | 96,259 | 31.00K |
| 246 | MNPR | Monopar Therapeutics Inc. | 376.81M | -5.10% | 260,788 | - |
| 247 | VSTM | Verastem, Inc. | 374.78M | -1.27% | 1,664,541 | 49.59M |
| 248 | BNTC | Benitec Biopharma Inc. | 374.12M | -5.22% | 64,235 | - |
| 249 | GLSI | Greenwich LifeSciences, Inc. | 372.41M | -1.21% | 78,306 | - |
| 250 | LXEO | Lexeo Therapeutics, Inc. | 369.84M | -7.47% | 858,758 | - |
| 251 | IFRX | InflaRx N.V. | 368.23M | 1.21% | 1,598,054 | 33.82K |
| 252 | VNDA | Vanda Pharmaceuticals Inc. | 365.62M | -3.18% | 1,419,164 | 217.78M |
| 253 | YDES | YD Bio Limited | 355.82M | -2.22% | 1,600 | 510.36K |
| 254 | CCCC | C4 Therapeutics, Inc. | 354.78M | -9.55% | 2,079,426 | 34.86M |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 347.10M | -6.60% | 493,599 | 9.01M |
| 256 | PBYI | Puma Biotechnology, Inc. | 346.63M | -1.59% | 177,000 | 227.18M |
| 257 | RZLT | Rezolute, Inc. | 338.47M | -2.99% | 1,488,552 | - |
| 258 | LRMR | Larimar Therapeutics, Inc. | 338.20M | -9.50% | 2,390,408 | - |
| 259 | RCKT | Rocket Pharmaceuticals, Inc. | 335.22M | -5.54% | 2,936,470 | - |
| 260 | FENC | Fennec Pharmaceuticals Inc. | 333.48M | -1.54% | 458,984 | 51.00M |
| 261 | OABI | OmniAb, Inc. | 331.99M | 5.05% | 1,461,833 | 28.94M |
| 262 | AVIR | Atea Pharmaceuticals, Inc. | 330.91M | 0.85% | 368,983 | - |
| 263 | CMPX | Compass Therapeutics, Inc. | 329.56M | -1.61% | 4,230,581 | 850.00K |
| 264 | NMRA | Neumora Therapeutics, Inc. | 323.36M | -3.80% | 838,753 | - |
| 265 | IVVD | Invivyd, Inc. | 319.57M | -6.61% | 3,159,137 | 55.87M |
| 266 | SRZN | Surrozen, Inc. | 317.84M | -1.71% | 42,484 | 7.49M |
| 267 | IRD | Opus Genetics, Inc. | 317.03M | -7.50% | 1,227,043 | 11.98M |
| 268 | IMRX | Immuneering Corporation | 315.08M | -5.62% | 1,084,467 | - |
| 269 | LCTX | Lineage Cell Therapeutics, Inc. | 309.13M | -0.80% | 1,454,734 | 14.78M |
| 270 | ABEO | Abeona Therapeutics Inc. | 306.06M | -2.19% | 812,777 | 14.54M |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 304.44M | -6.77% | 311,214 | - |
| 272 | BCYC | Bicycle Therapeutics plc | 303.92M | -2.02% | 336,791 | 63.50M |
| 273 | PALI | Palisade Bio, Inc. | 303.04M | -1.09% | 2,890,952 | - |
| 274 | NAUT | Nautilus Biotechnology, Inc. | 299.91M | -5.98% | 550,512 | - |
| 275 | NAGE | Niagen Bioscience, Inc. | 295.30M | 1.37% | 815,134 | 130.42M |
| 276 | NGEN | NervGen Pharma Corp. | 294.59M | 2.10% | 135,973 | - |
| 277 | SLN | Silence Therapeutics plc | 294.27M | 2.13% | 371,189 | 839.00K |
| 278 | RGNX | REGENXBIO Inc. | 292.09M | -1.22% | 2,598,037 | 87.82M |
| 279 | CLLS | Cellectis S.A. | 283.20M | -1.79% | 13,554 | 75.11M |
| 280 | ARMP | Armata Pharmaceuticals, Inc. | 278.88M | -5.59% | 157,581 | 5.20M |
| 281 | ELDN | Eledon Pharmaceuticals, Inc. | 276.74M | -5.79% | 1,111,698 | - |
| 282 | MGNX | MacroGenics, Inc. | 276.49M | 2.35% | 1,350,004 | 157.08M |
| 283 | NVCT | Nuvectis Pharma, Inc. | 275.87M | -5.80% | 180,836 | - |
| 284 | ACIU | AC Immune SA | 274.79M | -0.72% | 224,826 | 4.62M |
| 285 | IKT | Inhibikase Therapeutics, Inc. | 274.38M | -6.94% | 1,716,530 | 1.00 |
| 286 | CGEN | Compugen Ltd. | 270.42M | 4.00% | 1,702,226 | 72.76M |
| 287 | ALXO | ALX Oncology Holdings Inc. | 269.12M | -1.48% | 827,261 | - |
| 288 | AVXL | Anavex Life Sciences Corp. | 266.89M | -1.03% | 929,681 | - |
| 289 | TARA | Protara Therapeutics, Inc. | 258.54M | -9.80% | 1,019,089 | - |
| 290 | ZNTL | Zentalis Pharmaceuticals, Inc. | 258.41M | -10.37% | 3,193,928 | 26.87M |
| 291 | SABS | SAB Biotherapeutics, Inc. | 250.18M | -3.78% | 772,502 | 114.70K |
| 292 | EDIT | Editas Medicine, Inc. | 247.70M | -3.44% | 1,212,642 | 38.69M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 238.33M | 6.99% | 414,293 | 32.72M |
| 294 | CAMP | Camp4 Therapeutics Corporation | 236.78M | 5.80% | 43,481 | 3.93M |
| 295 | ALEC | Alector, Inc. | 235.37M | -1.85% | 814,451 | 18.42M |
| 296 | CDXS | Codexis, Inc. | 230.88M | 3.25% | 728,168 | 78.09M |
| 297 | CHRS | Coherus Oncology, Inc. | 229.83M | -5.10% | 1,772,219 | 46.88M |
| 298 | TNXP | Tonix Pharmaceuticals Holding Corp. | 227.32M | -9.40% | 592,787 | 17.56M |
| 299 | FHTX | Foghorn Therapeutics Inc. | 224.29M | 0.79% | 230,928 | 28.22M |
| 300 | ADAG | Adagene Inc. | 223.99M | -3.14% | 131,883 | 7.67M |
| 301 | SLGL | Sol-Gel Technologies Ltd. | 222.29M | -6.49% | 13,589 | 19.39M |
| 302 | HELP | Cybin Inc. | 222.16M | -4.93% | 1,009,920 | - |
| 303 | RNA | Atrium Therapeutics, Inc. | 221.52M | -2.12% | 146,590 | 36.68M |
| 304 | NERV | Minerva Neurosciences, Inc. | 220.36M | -9.21% | 122,266 | - |
| 305 | UNCY | Unicycive Therapeutics, Inc. | 217.61M | -1.33% | 486,470 | - |
| 306 | LENZ | LENZ Therapeutics, Inc. | 216.35M | -5.99% | 878,514 | 20.99M |
| 307 | VYGR | Voyager Therapeutics, Inc. | 213.29M | -6.24% | 828,168 | 36.49M |
| 308 | TRDA | Entrada Therapeutics, Inc. | 212.24M | -7.68% | 433,828 | 5.74M |
| 309 | MDWD | MediWound Ltd. | 210.58M | -0.15% | 50,552 | 16.96M |
| 310 | WHWK | Whitehawk Therapeutics, Inc. | 210.07M | -9.57% | 294,501 | 7.15M |
| 311 | CRBU | Caribou Biosciences, Inc. | 203.40M | -3.27% | 2,044,546 | 11.20M |
| 312 | RNAC | Cartesian Therapeutics, Inc. | 202.44M | -6.64% | 136,075 | 1.78M |
| 313 | FATE | Fate Therapeutics, Inc. | 201.65M | -1.42% | 2,101,427 | 6.32M |
| 314 | KROS | Keros Therapeutics, Inc. | 201.09M | -3.24% | 395,711 | 33.18M |
| 315 | ARCT | Arcturus Therapeutics Holdings Inc. | 199.81M | -5.89% | 610,026 | 54.71M |
| 316 | HUMA | Humacyte, Inc. | 199.46M | -3.41% | 6,360,142 | 2.02M |
| 317 | MIST | Milestone Pharmaceuticals Inc. | 198.63M | -2.99% | 1,194,722 | 1.78M |
| 318 | NBP | NovaBridge Biosciences | 197.76M | -6.04% | 1,174,391 | - |
| 319 | CNTX | Context Therapeutics Inc. | 197.54M | -0.46% | 638,472 | - |
| 320 | NKTX | Nkarta, Inc. | 191.74M | 1.52% | 827,754 | - |
| 321 | IPHA | Innate Pharma S.A. | 189.73M | 11.39% | 114,351 | 10.57M |
| 322 | CNTN | Canton Strategic Holdings, Inc. | 184.70M | -9.94% | 885,225 | - |
| 323 | DTIL | Precision BioSciences, Inc. | 179.58M | -4.26% | 444,098 | 45.07M |
| 324 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 176.48M | -9.79% | 232,854 | - |
| 325 | ELTX | Elicio Therapeutics, Inc. | 176.05M | -9.97% | 171,654 | - |
| 326 | ORMP | Oramed Pharmaceuticals Inc. | 173.92M | -7.33% | 379,779 | 2.00M |
| 327 | TLSA | Tiziana Life Sciences Ltd | 172.29M | -1.46% | 80,020 | - |
| 328 | TNYA | Tenaya Therapeutics, Inc. | 169.91M | -8.67% | 5,496,161 | 225.00K |
| 329 | ENLV | Enlivex Ltd. | 167.96M | -3.30% | 124,914 | - |
| 330 | HRTX | Heron Therapeutics, Inc. | 162.67M | 1.11% | 1,615,635 | 150.71M |
| 331 | HURA | TuHURA Biosciences, Inc. | 162.39M | 10.39% | 701,491 | - |
| 332 | ANTX | AN2 Therapeutics, Inc. | 161.80M | -5.37% | 119,208 | - |
| 333 | KPTI | Karyopharm Therapeutics Inc. | 161.02M | -6.91% | 571,964 | 151.12M |
| 334 | PRQR | ProQR Therapeutics N.V. | 159.62M | -4.72% | 503,024 | 15.73M |
| 335 | IMUX | Immunic, Inc. | 158.83M | -3.48% | 121,528 | - |
| 336 | ABOS | Acumen Pharmaceuticals, Inc. | 157.46M | -4.39% | 479,158 | - |
| 337 | PLX | Protalix BioTherapeutics, Inc. | 153.89M | -3.54% | 1,103,957 | 76.38M |
| 338 | MENS | Jyong Biotech Ltd. | 153.80M | -0.50% | 92,125 | - |
| 339 | SPRO | Spero Therapeutics, Inc. | 149.39M | -7.53% | 917,113 | 61.19M |
| 340 | BDTX | Black Diamond Therapeutics, Inc. | 147.84M | -6.18% | 678,341 | 70.00M |
| 341 | TTRX | Turn Therapeutics Inc. | 145.96M | 20.99% | 114,655 | - |
| 342 | GALT | Galectin Therapeutics Inc. | 144.16M | 0.92% | 283,649 | - |
| 343 | KRRO | Korro Bio, Inc. | 143.79M | -2.06% | 138,438 | 3.84M |
| 344 | KZIA | Kazia Therapeutics Limited | 143.52M | -4.56% | 378,804 | 1.27M |
| 345 | ALPS | Alps Group Inc | 141.46M | -3.94% | 3,516 | 3.74M |
| 346 | MOLN | Molecular Partners AG | 141.23M | -1.04% | 7,040 | 856.30K |
| 347 | SPRB | Spruce Biosciences, Inc. | 138.92M | -4.41% | 73,133 | 697.00K |
| 348 | CNTB | Connect Biopharma Holdings Limited | 136.22M | 1.26% | 130,731 | 233.00K |
| 349 | NTHI | NeOnc Technologies Holdings, Inc. | 134.51M | -2.91% | 39,330 | 39.99K |
| 350 | AGEN | Agenus Inc. | 131.26M | -11.73% | 1,011,484 | 123.87M |
| 351 | PLYX | Polaryx Therapeutics, Inc. | 130.67M | 3.37% | 161,711 | - |
| 352 | GUTS | Fractyl Health, Inc. | 127.93M | -6.30% | 2,111,005 | 3.00K |
| 353 | PYXS | Pyxis Oncology, Inc. | 126.97M | -11.40% | 452,760 | 13.86M |
| 354 | GNLX | Genelux Corporation | 126.57M | -2.40% | 161,946 | 8.00K |
| 355 | ACOG | Alpha Cognition Inc. | 125.20M | -4.49% | 61,357 | 10.83M |
| 356 | OKUR | OnKure Therapeutics, Inc. | 124.42M | -2.53% | 214,559 | - |
| 357 | EQ | Equillium, Inc. | 116.34M | -15.60% | 465,605 | 4.39M |
| 358 | COYA | Coya Therapeutics, Inc. | 115.64M | -0.60% | 256,246 | 7.94M |
| 359 | CRDF | Cardiff Oncology, Inc. | 115.55M | 1.20% | 1,095,262 | 525.00K |
| 360 | KLRS | Kalaris Therapeutics, Inc. | 108.41M | -3.78% | 77,505 | - |
| 361 | ENGN | enGene Therapeutics Inc. | 105.17M | -8.72% | 1,789,235 | - |
| 362 | NRXP | NRx Pharmaceuticals, Inc. | 102.90M | -5.03% | 1,966,134 | 2.29M |
| 363 | PEPG | PepGen Inc. | 101.68M | -5.16% | 834,127 | - |
| 364 | VRCA | Verrica Pharmaceuticals Inc. | 100.84M | -6.38% | 41,514 | 37.16M |
| 365 | INO | Inovio Pharmaceuticals, Inc. | 99.96M | -6.15% | 5,229,695 | 65.34K |
| 366 | VANI | Vivani Medical, Inc. | 98.31M | -2.56% | 138,189 | - |
| 367 | CBUS | Cibus, Inc. | 97.64M | -2.29% | 327,038 | 4.29M |
| 368 | QTTB | Q32 Bio Inc. | 97.50M | -8.73% | 244,936 | 53.74M |
| 369 | CGTX | Cognition Therapeutics, Inc. | 97.40M | -4.39% | 953,928 | - |
| 370 | RANI | Rani Therapeutics Holdings, Inc. | 97.05M | -9.97% | 1,416,520 | 3.17M |
| 371 | ALDX | Aldeyra Therapeutics, Inc. | 96.51M | -4.76% | 1,023,831 | - |
| 372 | AARD | Aardvark Therapeutics, Inc. | 95.12M | -4.60% | 279,700 | - |
| 373 | SEER | Seer, Inc. | 95.07M | -2.03% | 319,191 | 15.17M |
| 374 | LONA | LeonaBio, Inc. | 94.50M | -10.66% | 24,355 | - |
| 375 | PMN | ProMIS Neurosciences, Inc. | 93.58M | 0.43% | 27,013 | - |
| 376 | ONCY | Oncolytics Biotech Inc. | 92.91M | -5.87% | 1,135,427 | - |
| 377 | ANIX | Anixa Biosciences, Inc. | 92.54M | -2.13% | 114,180 | - |
| 378 | BMEA | Biomea Fusion, Inc. | 90.37M | -7.41% | 1,796,145 | - |
| 379 | PYPD | PolyPid Ltd. | 90.26M | 6.05% | 291,899 | - |
| 380 | ICCC | ImmuCell Corporation | 89.65M | 11.10% | 117,969 | 29.93M |
| 381 | PTHS | Pelthos Therapeutics Inc. | 87.75M | -2.13% | 27,161 | 27.70M |
| 382 | NRXS | NeurAxis, Inc. | 85.26M | -5.84% | 131,716 | 4.28M |
| 383 | CSBR | Champions Oncology, Inc. | 84.29M | -2.10% | 8,503 | 57.95M |
| 384 | OKYO | OKYO Pharma Limited | 82.92M | 0.64% | 57,913 | - |
| 385 | FBIO | Fortress Biotech, Inc. | 82.38M | 2.90% | 824,276 | 66.16M |
| 386 | RNTX | Rein Therapeutics Inc. | 81.16M | -0.95% | 453,751 | - |
| 387 | EXOZ | eXoZymes, Inc. | 80.97M | -2.15% | 3,466 | -700.00 |
| 388 | EDSA | Edesa Biotech, Inc. | 79.97M | -31.03% | 694,635 | - |
| 389 | ACET | Adicet Bio, Inc. | 78.76M | -2.34% | 100,876 | - |
| 390 | ATRA | Atara Biotherapeutics, Inc. | 77.89M | -4.49% | 381,110 | 23.14M |
| 391 | ATHE | Alterity Therapeutics Limited | 77.79M | 7.57% | 18,158 | 4.43M |
| 392 | MAIA | MAIA Biotechnology, Inc. | 76.45M | - | 632,792 | - |
| 393 | RLYB | Rallybio Corporation | 74.58M | -1.47% | 57,915 | 858.00K |
| 394 | MCRB | Seres Therapeutics, Inc. | 73.50M | -0.65% | 31,333 | 1.15M |
| 395 | XBIT | XBiotech Inc. | 73.17M | -2.44% | 39,195 | - |
| 396 | PLRX | Pliant Therapeutics, Inc. | 73.07M | 2.61% | 1,218,395 | - |
| 397 | OSTX | OS Therapies Incorporated | 72.73M | -7.98% | 1,780,353 | - |
| 398 | ANVS | Annovis Bio, Inc. | 71.03M | -0.49% | 769,651 | - |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 70.62M | -6.78% | 676,874 | - |
| 400 | CUE | Cue Biopharma, Inc. | 69.60M | -7.08% | 124,673 | 32.73M |
| 401 | GANX | Gain Therapeutics, Inc. | 69.10M | -7.43% | 995,777 | - |
| 402 | MNOV | MediciNova, Inc. | 68.42M | 0.72% | 7,821 | 596.64K |
| 403 | PMVP | PMV Pharmaceuticals, Inc. | 66.40M | -3.49% | 252,665 | - |
| 404 | PDSB | PDS Biotechnology Corporation | 65.86M | -11.94% | 1,066,720 | - |
| 405 | IMMP | Immutep Limited | 64.30M | -4.95% | 1,045,862 | 5.28M |
| 406 | IMA | ImageneBio, Inc. | 64.29M | 0.35% | 14,860 | 800.00K |
| 407 | HYFT | MindWalk Holdings Corp. | 62.58M | 5.88% | 378,798 | 20.70M |
| 408 | ENTX | Entera Bio Ltd. | 60.55M | -2.38% | 104,615 | 42.00K |
| 409 | TCRX | TScan Therapeutics, Inc. | 60.10M | - | 501,395 | 9.14M |
| 410 | ACTU | Actuate Therapeutics, Inc. | 58.14M | -7.25% | 85,491 | - |
| 411 | IBO | Impact BioMedical Inc. | 58.04M | 0.13% | 18,653 | 39.00K |
| 412 | FLNA | Filana Therapeutics, Inc. | 57.49M | 0.85% | 362,283 | - |
| 413 | BYSI | BeyondSpring Inc. | 57.36M | 2.57% | 29,029 | 1.88M |
| 414 | DWTX | Dogwood Therapeutics, Inc. | 56.78M | -7.10% | 33,635 | - |
| 415 | TIL | Instil Bio, Inc. | 55.14M | 0.74% | 49,897 | - |
| 416 | CING | Cingulate Inc. | 54.88M | -1.97% | 445,159 | - |
| 417 | LIXT | Lixte Biotechnology Holdings, Inc. | 54.60M | -8.91% | 67,379 | - |
| 418 | IBIO | iBio, Inc. | 51.32M | -3.40% | 746,232 | 300.00K |
| 419 | ATYR | aTyr Pharma, Inc. | 50.94M | 3.08% | 5,243,906 | 190.00K |
| 420 | RADX | Radiopharm Theranostics Limited | 50.67M | 0.85% | 58,287 | 10.86M |
| 421 | KALA | KALA BIO, Inc. | 50.38M | -7.51% | 52,311 | - |
| 422 | INKT | MiNK Therapeutics, Inc. | 50.02M | -6.34% | 28,235 | - |
| 423 | XLO | Xilio Therapeutics, Inc. | 48.76M | -2.51% | 51,894 | 53.48M |
| 424 | MGX | Metagenomi Therapeutics, Inc. | 47.81M | -3.05% | 228,823 | 22.33M |
| 425 | ESLA | Estrella Immunopharma, Inc. | 47.79M | 0.90% | 26,126 | - |
| 426 | HYPD | Hyperion DeFi, Inc. | 45.32M | -5.06% | 623,161 | 1.04M |
| 427 | GOSS | Gossamer Bio, Inc. | 45.23M | -43.32% | 56,927,276 | 55.54M |
| 428 | NTRB | Nutriband Inc. | 41.57M | -5.00% | 19,703 | 2.04M |
| 429 | ATOS | Atossa Therapeutics, Inc. | 41.16M | -1.44% | 41,445 | - |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 40.91M | -5.56% | 81,156 | - |
| 431 | PSTV | Plus Therapeutics, Inc. | 40.07M | 11.24% | 275,623 | 5.18M |
| 432 | LITS | Lite Strategy, Inc. | 39.82M | -6.41% | 551,719 | - |
| 433 | INMB | INmune Bio Inc. | 39.61M | -3.87% | 346,620 | 50.00K |
| 434 | QNTM | Quantum BioPharma Ltd. | 39.31M | -7.93% | 479,488 | - |
| 435 | MREO | Mereo BioPharma Group plc | 37.89M | -1.70% | 1,346,169 | 500.00K |
| 436 | TVRD | Tvardi Therapeutics, Inc. | 37.53M | - | 66,863 | - |
| 437 | TVGN | Tevogen Bio Holdings Inc. | 37.19M | 11.70% | 15,119 | - |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 36.48M | -6.40% | 105,674 | 90.00K |
| 439 | RNXT | RenovoRx, Inc. | 35.29M | -4.49% | 403,771 | 1.49M |
| 440 | EVAX | Evaxion A/S | 34.11M | 4.34% | 28,596 | 7.53M |
| 441 | VERU | Veru Inc. | 34.03M | 0.47% | 85,666 | 16.89M |
| 442 | LTRN | Lantern Pharma Inc. | 33.63M | -4.46% | 367,883 | - |
| 443 | NXTC | NextCure, Inc. | 33.37M | -5.03% | 27,577 | - |
| 444 | GRCE | Grace Therapeutics, Inc. | 33.35M | -0.23% | 409,559 | - |
| 445 | ALGS | Aligos Therapeutics, Inc. | 33.17M | -6.13% | 165,124 | 4.71M |
| 446 | NNVC | NanoViricides, Inc. | 32.61M | 2.03% | 1,087,569 | - |
| 447 | BOLD | Boundless Bio, Inc. | 32.28M | -3.36% | 197,210 | - |
| 448 | APLM | Apollomics, Inc. | 31.41M | -4.64% | 131 | 8.84M |
| 449 | PLUR | Pluri Inc. | 31.36M | -7.42% | 15,312 | 1.08M |
| 450 | DARE | Daré Bioscience, Inc. | 30.72M | -2.76% | 482,504 | 1.16M |
| 451 | SNTI | Senti Biosciences Holdings, Inc. | 29.28M | -6.92% | 279,659 | 38.00K |
| 452 | IGC | IGC Pharma, Inc. | 28.26M | - | 633,294 | 1.11M |
| 453 | LSTA | Lisata Therapeutics, Inc. | 28.18M | -1.58% | 3,527 | 170.00K |
| 454 | CRVO | CervoMed Inc. | 28.15M | -11.63% | 163,011 | 2.09M |
| 455 | KYNB | Kyntra Bio, Inc. | 27.65M | 0.15% | 11,100 | 7.44M |
| 456 | PTN | Palatin Technologies, Inc. | 27.52M | 5.76% | 31,453 | 12.88M |
| 457 | SKYE | Skye Bioscience, Inc. | 27.32M | -4.41% | 100,107 | - |
| 458 | NRSN | NeuroSense Therapeutics Ltd. | 27.23M | -6.81% | 233,231 | - |
| 459 | SNSE | Sensei Biotherapeutics, Inc. | 26.69M | -2.55% | 47,399 | - |
| 460 | TRAW | Traws Pharma, Inc. | 26.67M | -6.38% | 783,474 | 2.73M |
| 461 | DYAI | Dyadic International, Inc. | 26.24M | -0.26% | 161,414 | 3.81M |
| 462 | ABVC | ABVC BioPharma, Inc. | 26.19M | -2.75% | 126,439 | 797.92K |
| 463 | TPST | Tempest Therapeutics, Inc. | 26.11M | -0.55% | 42,603 | - |
| 464 | BRNS | Barinthus Biotherapeutics plc | 26.08M | -6.05% | 72,807 | 14.97M |
| 465 | PLRZ | Polyrizon Ltd. | 25.66M | -7.36% | 5,157 | - |
| 466 | NEUP | Neuphoria Therapeutics Inc. | 25.45M | -0.21% | 38,171 | -13.27K |
| 467 | HOWL | Werewolf Therapeutics, Inc. | 24.07M | -3.84% | 414,107 | 1.14M |
| 468 | VTGN | Vistagen Therapeutics, Inc. | 24.03M | -2.93% | 529,666 | 789.00K |
| 469 | OTLK | Outlook Therapeutics, Inc. | 23.98M | 0.48% | 2,597,019 | 333.14K |
| 470 | GRDX | GridAI Technologies Corp. | 23.44M | -2.33% | 77,302 | - |
| 471 | MRKR | Marker Therapeutics, Inc. | 23.18M | -2.11% | 35,697 | 3.55M |
| 472 | CELU | Celularity Inc. | 23.02M | -1.22% | 45,442 | 26.55M |
| 473 | JSPR | Jasper Therapeutics, Inc. | 22.58M | -5.12% | 199,523 | - |
| 474 | VYNE | VYNE Therapeutics Inc. | 22.54M | 0.94% | 728,117 | 454.00K |
| 475 | SER | Serina Therapeutics, Inc. | 22.50M | -7.93% | 37,596 | 130.00K |
| 476 | AEON | AEON Biopharma, Inc. | 22.49M | 18.49% | 254,040 | - |
| 477 | ALLR | Allarity Therapeutics, Inc. | 22.11M | 5.93% | 156,909 | 345.00K |
| 478 | BCTX | BriaCell Therapeutics Corp. | 21.76M | 10.93% | 363,975 | - |
| 479 | LGVN | Longeveron Inc. | 19.80M | 0.84% | 392,962 | 1.22M |
| 480 | KTTA | Pasithea Therapeutics Corp. | 19.20M | -1.29% | 67,881 | - |
| 481 | CRIS | Curis, Inc. | 19.19M | -2.08% | 292,750 | 7.06M |
| 482 | XCUR | Exicure, Inc. | 18.93M | 4.58% | 23,816 | 500.00K |
| 483 | LPCN | Lipocine Inc. | 17.74M | -2.21% | 83,884 | 2.00M |
| 484 | OSRH | OSR Holdings, Inc. | 17.31M | -8.30% | 1,255,117 | 2.63M |
| 485 | NCEL | NewcelX Ltd. | 16.69M | -3.43% | 10,428 | - |
| 486 | PASG | Passage Bio, Inc. | 16.42M | -1.92% | 45,684 | - |
| 487 | COCP | Cocrystal Pharma, Inc. | 16.27M | -1.67% | 172,099 | 225.00K |
| 488 | QNCX | Quince Therapeutics, Inc. | 16.22M | -13.50% | 23,497,598 | - |
| 489 | ICU | SeaStar Medical Holding Corporation | 15.99M | 1.27% | 24,241 | 1.44M |
| 490 | GNTA | Genenta Science S.p.A. | 14.90M | 0.59% | 34,869 | - |
| 491 | CVKD | Cadrenal Therapeutics, Inc. | 14.84M | -4.65% | 47,576 | - |
| 492 | GDTC | CytoMed Therapeutics Limited | 14.32M | 4.31% | 120,750 | 669.28K |
| 493 | ERNA | Ernexa Therapeutics Inc. | 14.29M | -10.12% | 234,508 | 1,000.00 |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 14.29M | -24.76% | 2,529,647 | 5.61M |
| 495 | INAB | IN8bio, Inc. | 14.08M | -4.03% | 89,552 | - |
| 496 | CVM | CEL-SCI Corporation | 13.92M | 20.28% | 1,416,408 | - |
| 497 | LEXX | Lexaria Bioscience Corp. | 13.88M | -5.42% | 54,055 | 368.00K |
| 498 | TOVX | Theriva Biologics, Inc. | 13.54M | 1.41% | 1,504,464 | 300.00K |
| 499 | CLRB | Cellectar Biosciences, Inc. | 13.31M | 1.62% | 241,026 | - |
| 500 | HIND | Vyome Holdings, Inc. | 13.27M | - | 26,337 | 152.72K |